Oralmat - Original Page

Oralmat has undergone recent clinical trials showing conclusively that it greatly benefits people suffering from asthma.

The clinical trial, conducted by John Hunter University (Newcastle, Australia), used standard methodology: a placebo controlled double-blind cross-over format. The results appear to show that individuals' asthma symptoms were lessened by using the product. Not only that, but some of the individuals indicated signs of improvement after only a few days of using the Oralmat. The John Hunter team doing the asthma trial reported verbally - in the early days of the trial - that many people were coming after a few days of being on the "active" and reporting that they were feeling better within themselves. They commented that they had never seen that before.

Based on pilot studies already released, it is believed that asthmatics may become so free of symptoms after using the product for three months and that they might only to carry their puffers as a precaution. That may mean that Oralmat could completely revolutionise the progression of a disease which affects up to 25% of populations in certain pockets of the world. So people whose breathing is affected by pollution, high pollen counts, and certain foods might look to Oralmat? as a possible means of alleviating their problem.
Oralmat may also be of benefit for the following symptoms:

(Note that the following reports are merely anecdotal and are not currently supported by clinical studies)

Viruses for the common cold and influenza - Clinical reports from a medical practitioner indicate that a number of people using Oralmat might have found that a few drops under the tongue at the first sign of symptoms thwart the progress of the infection. The dose must be repeated three times per day until symptoms clear. The Australian National University has agreed to use Oralmat in a clinical trial against the common cold and influenza. Bureaucratic indifference is said to have prevented the results of the study from reaching the light of day

Raynaud's Syndrome - a general practitioner working with the cream version of the product (Acno) discovered that by applying a small amount to the palmar surface of the little finger of an infected person's freedom of movement, colour, circulation and improvement of other symptoms was reported within 30 minutes.1

Rheumatoid Arthritis - similar results were found in several elderly people suffering from RA. A small amount of cream applied to the source of the pain reduced the symptoms1.

Broken bones - a patient reported that the pain from her broken arm was reduced within 30 minutes of applying the Oralmat. Ordinary prescribed analgesics had failed to remove the pain - but it is understood that the patient was still using these at the time1.

Varicose Ulcers - a small amount of the cream applied to an entrenched varicose ulcer produced healing after 21 days of usage. This ulcer had been with the elderly diabetic sufferer for approximately 2 years and had not responded to any other treatment1.

Mouth Ulcers - in a clinical study (not placebo controlled) at Beijing University (around 1994), 16 of 22 sufferers of radiation induced mouth ulcers experienced healing of their ulcers. Of the remaining six, four were completely healed after a further few days of treatment (outside the parameters of the study), and the remaining two cleared up a week later3.

Apthous Ulcers - in a study conducted by a group of dentists in Melbourne, ulcers graded into three classes were treated using the Oralmat Spray, and it was found that the expected healing rate was halved when compared to the use of standard medication.

Race Horses - an outbreak of herpes equine virus was claimed to be eliminated in three days in a stable of 28 horses by the use of Oralmat. Dose used was 1ml sublingually 3 times per day2.

Athletic Performance - a Melbourne football team used Oralmat? on its players and results across the board showed marked improvement2.

AIDS - Philip Princetta, D.C., operating an AIDS clinic in Atlanta, has produced consistently favourable results with patients in the physical area of weight gain/loss and energy - and in the area of haemotology - where there has been a consistent rise in white blood cell count. He has documented this in several letters2.

1. Clinical Reports of individual Patients are useful anecdotal evidence and represent the lowest grade of evidence (Grade 5)

2. Multi-person clinical studies of patterns without placebo control provide useful anecdotal evidence and represent Grade 4 evidence

3. Small scale (22+ people) clinical trials in a hospital setting without placebo control provide excellent evidence and represent Grade 3 Evidence

[Privacy Policy] [Copyright]
Click Here to Email Us - Lane Cove Wellness Centre - 152 Burns Bay Road, Lane Cove, NSW, 2066
(Ph): +61-2-9420-4959  (Fax):+61-2-9418-6846